4.0 Article

Generation of a KOR-Cre knockin mouse strain to study cells involved in kappa opioid signaling

Journal

GENESIS
Volume 54, Issue 1, Pages 29-37

Publisher

WILEY-BLACKWELL
DOI: 10.1002/dvg.22910

Keywords

genetics; opioid; OPRK1; KOPr; Cre-loxP system

Funding

  1. NIH [R01 AR063772, R21 AR064445 R37 AA10422, T32 NS 73548-3]
  2. Rita Allen Foundation
  3. Mouse Gene Manipulation Facility of the Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (IDDRC) [NIHP30-HD 18655, R21NS086117]

Ask authors/readers for more resources

The kappa opioid receptor (KOR) has numerous important roles in the nervous system including the modulation of mood, reward, pain, and itch. In addition, KOR is expressed in many non-neuronal tissues. However, the specific cell types that express KOR are poorly characterized. Here, we report the development of a KOR-Cre knockin allele, which provides genetic access to cells that express KOR. In this mouse, Cre recombinase (Cre) replaces the initial coding sequence of the Opkr1 gene (encoding the kappa opioid receptor). We demonstrate that the KOR-Cre allele mediates recombination by embryonic day 14.5 (E14.5). Within the brain, KOR-Cre shows expression in numerous areas including the cerebral cortex, nucleus accumbens and striatum. In addition, this allele is expressed in epithelium and throughout many regions of the body including the heart, lung, and liver. Finally, we reveal that KOR-Cre mediates recombination of a subset of bipolar and amacrine cells in the retina. Thus, the KOR-Cre mouse line is a valuable new tool for conditional gene manipulation to enable the study of KOR. genesis 54:29-37, 2016. (c) 2015 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available